{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Hsp90", "MDR", "P-gp", "SPR", "apoptosis", "isatin", "molecular docking and dynamics", "synergism with doxorubicin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35011321", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "24"}], "Language": ["eng"], "ELocationID": ["90", "10.3390/molecules27010090"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "24"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.", "Abstract": {"AbstractText": ["Breast cancer is a complex and multi-drug resistant (MDR) disease, which could result in the failure of many chemotherapeutic clinical agents. Discovering effective molecules from natural products or by derivatization from known compounds is the interest of many research studies. The first objective of the present study is to investigate the cytotoxic combinatorial, chemosensitizing, and apoptotic effects of an isatin derived compound (5,5-diphenylimidazolidine-2,4-dione conjugated with 5-substituted isatin, named HAA<sub>2021</sub> in the present study) against breast cancer cells (MCF7) and breast cancer cells resistant to doxorubicin (MCF7/ADR) when combined with doxorubicin. The second objective is to investigate the binding mode of HAA<sub>2021</sub> withP-glycoprotein (P-gp) and heat shock protein 90 (Hsp90), and to determine whether their co-inhibition by HAA<sub>2021</sub> contribute to the increase of the chemosensitization of MCF7/ADR cells to doxorubicin. The combination of HAA<sub>2021</sub>, at non-toxic doses, with doxorubicin synergistically inhibited the proliferation while inducing significant apoptosis in MCF7 cells. Moreover, HAA<sub>2021</sub> increased the chemosensitization of MCF7/ADR cells to doxorubicin, resulting in increased cytotoxicity/selectivity and apoptosis-inducing efficiency compared with the effect of doxorubicin or HAA<sub>2021</sub> alone against MCF7/ADR cells. Molecular modeling showed that two molecules of HAA<sub>2021</sub> bind to P-gp at the same time, causing P-gp inhibitory effect of the MDR efflux pump, and accumulation of Rhodamine-123 (Rho123) in MCF7/ADR cells. Furthermore, HAA<sub>2021</sub> stably interacted with Hsp90\u03b1 more efficiently compared with 17-<i>N</i>-allylamino-17-demethoxygeldanamycin (17-AAG), which was confirmed with the surface plasmon resonance (SPR) and molecular modeling studies. Additionally, HAA<sub>2021</sub> showed multi-target effects via the inhibition of Hsp90 and nuclear factor kappa B (NF-\ud835\udf05B) proteins in MCF7 and MCF7/ADR cells. Results of real time-PCR also confirmed the synergistic co-inhibition of P-gp/Hsp90\u03b1 genes in MCF7/ADR cells. Further pharmacokinetic and in vivo studies are warranted for HAA<sub>2021</sub> to confirm its anticancer capabilities."]}, "AuthorList": [{"Identifier": ["0000-0003-4770-9319"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Institute, National Center for Research, Khartoum 2404, Sudan."}], "LastName": "Abdalla", "ForeName": "Ashraf N", "Initials": "AN"}, {"Identifier": ["0000-0001-6727-5816"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Pisa, 56126 Pisa, Italy."}], "LastName": "Di Stefano", "ForeName": "Miriana", "Initials": "M"}, {"Identifier": ["0000-0002-8061-5632"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Pisa, 56126 Pisa, Italy."}], "LastName": "Poli", "ForeName": "Giulio", "Initials": "G"}, {"Identifier": ["0000-0002-6205-4069"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Pisa, 56126 Pisa, Italy."}], "LastName": "Tuccinardi", "ForeName": "Tiziano", "Initials": "T"}, {"Identifier": ["0000-0003-2201-7201"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Bader", "ForeName": "Ammar", "Initials": "A"}, {"Identifier": ["0000-0001-7937-3309"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze, Universit\u00e0 Degli Studi della Basilicata, 85100 Potenza, Italy."}], "LastName": "Vassallo", "ForeName": "Antonio", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Abdallah", "ForeName": "Mohamed E", "Initials": "ME"}, {"Identifier": ["0000-0001-8398-5412"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt."}], "LastName": "El-Readi", "ForeName": "Mahmoud Zaki", "Initials": "MZ"}, {"Identifier": ["0000-0003-4267-1016"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Refaat", "ForeName": "Bassem", "Initials": "B"}, {"Identifier": ["0000-0002-2021-8731"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Algarni", "ForeName": "Alanood S", "Initials": "AS"}, {"Identifier": ["0000-0001-6490-8219"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Alternative Medicines, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia."}], "LastName": "Ahmad", "ForeName": "Rizwan", "Initials": "R"}, {"Identifier": ["0000-0002-6983-8587"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Alkahtani", "ForeName": "Hamad M", "Initials": "HM"}, {"Identifier": ["0000-0002-3362-9337"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Abdel-Aziz", "ForeName": "Alaa A-M", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "El-Azab", "ForeName": "Adel S", "Initials": "AS"}, {"Identifier": ["0000-0003-0855-2013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Alqathama", "ForeName": "Aljawharah", "Initials": "A"}], "GrantList": [{"GrantID": "19-MED-1-02-0004", "Agency": "Umm al-Qura University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "ATP Binding Cassette Transporter, Subfamily B, Member 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "HSP90 Heat-Shock Proteins"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "82X95S7M06", "NameOfSubstance": "Isatin"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "ATP Binding Cassette Transporter, Subfamily B, Member 1"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Multiple"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "HSP90 Heat-Shock Proteins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Isatin"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "No conflict of interest is declared."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Talevi A. Multi-target pharmacology: Possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective. Front Pharm. 2015;6:205. doi: 10.3389/fphar.2015.00205.", "ArticleIdList": ["10.3389/fphar.2015.00205", "PMC4585027", "26441661"]}, {"Citation": "Neophytou C.M., Trougakos I.P., Erin N., Papageorgis P. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers. 2021;13:4363. doi: 10.3390/cancers13174363.", "ArticleIdList": ["10.3390/cancers13174363", "PMC8430856", "34503172"]}, {"Citation": "Housman G., Byler S., Heerboth S., Lapinska K., Longacre M., Snyder N., Sarkar S. Drug resistance in cancer: An overview. Cancers. 2014;6:1769\u20131792. doi: 10.3390/cancers6031769.", "ArticleIdList": ["10.3390/cancers6031769", "PMC4190567", "25198391"]}, {"Citation": "Yang M., Li H., Li Y., Ruan Y., Quan C. Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis. Mol. Med. Rep. 2018;17:6211\u20136226. doi: 10.3892/mmr.2018.8704.", "ArticleIdList": ["10.3892/mmr.2018.8704", "PMC5928598", "29512753"]}, {"Citation": "Abdalla A.N., Malki W.H., Qattan A., Shahid I., Hossain M.A., Ahmed M. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. Molecules. 2021;26:334. doi: 10.3390/molecules26020334.", "ArticleIdList": ["10.3390/molecules26020334", "PMC7827067", "33440689"]}, {"Citation": "El-Azab A.S., Al-Dhfyan A., Abdel-Aziz A.A.M., Abou-Zeid L.A., Alkahtani H.M., Al-Obaid A.M., Al-Gendy M.A. Synthesis, anticancer and apoptosis-inducing activities of quinazoline\u2013isatin conjugates: Epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies. J. Enzym. Inhib. Med. Chem. 2017;27:682\u2013693. doi: 10.1080/14756366.2017.1344981.", "ArticleIdList": ["10.1080/14756366.2017.1344981", "PMC6445199", "28718672"]}, {"Citation": "Korashy H.M., Maayah Z.H., Al Anazi F.E., Alsaad A.M., Alanazi I.O., Belali O.M., Al-Atawi F.O., Alshamsan A. Sunitinib inhibits breast cancer cell proliferation by inducing apoptosis, cell-cycle arrest and DNA repair while inhibiting NF-\u03baB signaling pathways. Anticancer Res. 2017;37:4899\u20134909.", "ArticleIdList": ["28870911"]}, {"Citation": "Xia L., Tan S., Zhou Y., Lin J., Wang H., Oyang L., Tian Y., Liu L., Su M., Wang H., et al. Role of the NF\u03baB-signaling pathway in cancer. OncoTargets Ther. 2018;11:2063\u20132073. doi: 10.2147/OTT.S161109.", "ArticleIdList": ["10.2147/OTT.S161109", "PMC5905465", "29695914"]}, {"Citation": "Tsou S.H., Chen T.M., Hsiao H.T., Chen Y.H. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance. PLoS ONE. 2015;10:e0116747. doi: 10.1371/journal.pone.0116747.", "ArticleIdList": ["10.1371/journal.pone.0116747", "PMC4312059", "25635866"]}, {"Citation": "Bruns A.F., Yuldasheva N., Latham A.M., Bao L., Pellet-Many C., Frankel P., Stephen S.L., Howell G.J., Wheatcroft S.B., Kearney M.T., et al. A heat-shock protein axis regulates VEGFR2 proteolysis, blood vessel development and repair. PLoS ONE. 2012;7:e48539. doi: 10.1371/journal.pone.0048539.", "ArticleIdList": ["10.1371/journal.pone.0048539", "PMC3491040", "23139789"]}, {"Citation": "Pandeya S.N., Smitha S., Jyoti M., Sridhar S.K. Biological activities of isatin and its derivatives. Acta Pharm. 2005;55:27\u201346.", "ArticleIdList": ["15907222"]}, {"Citation": "Fouche G., Cragg G.M., Pillay P., Kolesnikova N., Maharaj V.J., Senabe J. In vitro anticancer screening of South African plants. J. Ethnopharmacol. 2008;119:455\u2013461. doi: 10.1016/j.jep.2008.07.005.", "ArticleIdList": ["10.1016/j.jep.2008.07.005", "18678239"]}, {"Citation": "Ren X., Xie X., Chen B., Liu L., Jiang C., Qian Q. Marine Natural Products: A Potential Source of Anti-hepatocellular Carcinoma Drugs. J. Med. Chem. 2021;64:7879\u20137899. doi: 10.1021/acs.jmedchem.0c02026.", "ArticleIdList": ["10.1021/acs.jmedchem.0c02026", "34128674"]}, {"Citation": "Ringel I., Horwitz S.B. Studies with RP 56976 (taxotere): A semisynthetic analogue of taxol. J. Natl. Cancer Inst. 1991;83:288\u2013291. doi: 10.1093/jnci/83.4.288.", "ArticleIdList": ["10.1093/jnci/83.4.288", "1671606"]}, {"Citation": "Chadha N., Silakari O. Indoles as therapeutics of interest in medicinal chemistry: Bird\u2019s eye view. Eur. J. Med. Chem. 2017;134:159\u2013184. doi: 10.1016/j.ejmech.2017.04.003.", "ArticleIdList": ["10.1016/j.ejmech.2017.04.003", "28412530"]}, {"Citation": "Havrylyuk D., Kovach N., Zimenkovsky B., Vasylenko O., Lesyk R. Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates. Arch. Pharm. 2011;344:514\u2013522. doi: 10.1002/ardp.201100055.", "ArticleIdList": ["10.1002/ardp.201100055", "21681810"]}, {"Citation": "Singh H., Singh J.V., Gupta M.K., Saxena A.K., Sharma S., Nepali K., Bedi P.M.S. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Bioorg. Med. Chem. Lett. 2017;27:3974\u20133979. doi: 10.1016/j.bmcl.2017.07.069.", "ArticleIdList": ["10.1016/j.bmcl.2017.07.069", "28797799"]}, {"Citation": "Hamed A.R., Abdel-Azim N.S., Shams K.A., Hammouda F.M. Targeting multidrug resistance in cancer by natural chemosensitizers. Bull. Natl. Res. Cent. 2019;43:8. doi: 10.1186/s42269-019-0043-8.", "ArticleIdList": ["10.1186/s42269-019-0043-8"]}, {"Citation": "Zhang L., Chen F., Wang J., Chen Y., Zhang Z., Lin Y., Zhu X. Novel isatin derivatives of podophyllotoxin: Synthesis and cytotoxic evaluation against human leukaemia cancer cells as potent anti-MDR agents. RSC Adv. 2015;5:97816\u201397823. doi: 10.1039/C5RA21217K.", "ArticleIdList": ["10.1039/C5RA21217K"]}, {"Citation": "Rajesh Kumar M., Violet Dhayabaran V., Sudhapriya N., Manikandan A., Gideon D.A., Annapoorani S. p-TSA. H2O mediated one-pot, multi-component synthesis of isatin derived imidazoles as dual-purpose drugs against inflammation and cancer. Bioorg. Chem. 2020;102:104046. doi: 10.1016/j.bioorg.2020.104046.", "ArticleIdList": ["10.1016/j.bioorg.2020.104046", "32688115"]}, {"Citation": "Havrylyuk D., Zimenkovsky B., Vasylenko O., Gzella A., Lesyk R. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. J. Med. Chem. 2012;55:8630\u20138641. doi: 10.1021/jm300789g.", "ArticleIdList": ["10.1021/jm300789g", "22992049"]}, {"Citation": "Medvedev A., Buneeva O., Gnedenko O., Ershov P., Ivanov A. Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications. BioFactors. 2018;44:95\u2013108. doi: 10.1002/biof.1408.", "ArticleIdList": ["10.1002/biof.1408", "29336068"]}, {"Citation": "Pakravan P., Kashanian S., Khodaei M.M., Harding F.J. Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity. Pharmacol. Rep. 2013;65:313\u2013335. doi: 10.1016/S1734-1140(13)71007-7.", "ArticleIdList": ["10.1016/S1734-1140(13)71007-7", "23744416"]}, {"Citation": "Evdokimov N.M., Magedov I.V., McBrayer D., Kornienko A. Isatin derivatives with activity against apoptosis-resistant cancer cells. Bioorg. Med. Chem. Lett. 2016;26:1558\u20131560. doi: 10.1016/j.bmcl.2016.02.015.", "ArticleIdList": ["10.1016/j.bmcl.2016.02.015", "PMC4775416", "26883150"]}, {"Citation": "Chu W., Rothfuss J., Zhou D., MacH R.H. Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: Introduction of a hydrophilic group increases potency in a whole cell assay. Bioorg. Med. Chem. Lett. 2011;21:2192\u20132197. doi: 10.1016/j.bmcl.2011.03.015.", "ArticleIdList": ["10.1016/j.bmcl.2011.03.015", "PMC3075238", "21441025"]}, {"Citation": "Chinchar E., Makey K.L., Gibson J., Chen F., Cole S.A., Megason G.C., Vijayakumar S., Miele L., Gu J.W. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells. Vasc. Cell. 2014;6:12. doi: 10.1186/2045-824X-6-12.", "ArticleIdList": ["10.1186/2045-824X-6-12", "PMC4049452", "24914410"]}, {"Citation": "Alkahtani H.M., Alanazi M.M., Aleanizy F.S., Alqahtani F.Y., Alhoshani A., Alanazi F.E., Almehizia A.A., Abdalla A.N., Alanazi M.G., El-Azab A.S., et al. Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies. Saudi Pharm. J. 2019;27:682\u2013693. doi: 10.1016/j.jsps.2019.04.003.", "ArticleIdList": ["10.1016/j.jsps.2019.04.003", "PMC6598223", "31297023"]}, {"Citation": "Nosol K., Romane K., Irobalieva R.N., Alam A., Kowal J., Fujita N., Locher K.P. Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc. Natl. Acad. Sci. USA. 2020;117:26245\u201326253. doi: 10.1073/pnas.2010264117.", "ArticleIdList": ["10.1073/pnas.2010264117", "PMC7585025", "33020312"]}, {"Citation": "Cooper M.A. Label-free screening of bio-molecular interactions. Anal. Bioanal. Chem. 2003;77:834\u2013842. doi: 10.1007/s00216-003-2111-y.", "ArticleIdList": ["10.1007/s00216-003-2111-y", "12904946"]}, {"Citation": "Caputo M., De Rosa M.C., Rescigno T., Zirpoli H., Vassallo A., De Tommasi N., Torino G., Tecce M.F. Binding of polyunsaturated fatty acids to LXR\u03b1 and modulation of SREBP-1 interaction with a specific SCD1 promoter element. Cell Biochem. Funct. 2014;32:637\u2013646. doi: 10.1002/cbf.3067.", "ArticleIdList": ["10.1002/cbf.3067", "25264165"]}, {"Citation": "Malafronte N., Vassallo A., Dal Piaz F., Bader A., Braca A., De Tommasi N. Biflavonoids from Daphne linearifolia Hart. Phytochem. Lett. 2012;5:621\u2013625. doi: 10.1016/j.phytol.2012.06.008.", "ArticleIdList": ["10.1016/j.phytol.2012.06.008"]}, {"Citation": "Dal Piaz F., Vera Saltos M.B., Franceschelli S., Forte G., Marzocco S., Tuccinardi T., Poli G., Nejad Ebrahimi S., Hamburger M., De Tommasi N. Drug Affinity Responsive Target Stability (DARTS) Identifies Laurifolioside as a New Clathrin Heavy Chain Modulator. J. Nat. Prod. 2016;79:2681\u20132692. doi: 10.1021/acs.jnatprod.6b00627.", "ArticleIdList": ["10.1021/acs.jnatprod.6b00627", "27704815"]}, {"Citation": "Terracciano S., Chini M.G., Vaccaro M.C., Strocchia M., Foglia A., Vassallo A., Saturnino C., Riccio R., Bifulco G., Bruno I. Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors. Chem. Commun. 2016;52:12857\u201312860. doi: 10.1039/C6CC06379A.", "ArticleIdList": ["10.1039/C6CC06379A", "27731433"]}, {"Citation": "Schulte T.W., Akinaga S., Soga S., Sullivan W., Stensgard B., Toft D., Neckers L.M. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaperones. 1998;3:100. doi: 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2.", "ArticleIdList": ["10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2", "PMC312953", "9672245"]}, {"Citation": "Guo W., Reigan P., Siegel D., Zirrolli J., Gustafson D., Ross D. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition. Cancer Res. 2005;65:10006\u201310015. doi: 10.1158/0008-5472.CAN-05-2029.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-2029", "16267026"]}, {"Citation": "Camero C.M., Vassallo A., De Leo M., Temraz A., De Tommasi N., Braca A. Limonoids from Aphanamixis polystachya Leaves and Their Interaction with Hsp90. Planta Med. 2018;84:964\u2013970. doi: 10.1055/a-0624-9538.", "ArticleIdList": ["10.1055/a-0624-9538", "29763943"]}, {"Citation": "Amaral M., Kokh D.B., Bomke J., Wegener A., Buchstaller H.P., Eggenweiler H.M., Matias P., Sirrenberg C., Wade R.C., Frech M. Protein conformational flexibility modulates kinetics and thermodynamics of drug binding. Nat. Commun. 2017;8:2276. doi: 10.1038/s41467-017-02258-w.", "ArticleIdList": ["10.1038/s41467-017-02258-w", "PMC5741624", "29273709"]}, {"Citation": "Poli G., Lapillo M., Granchi C., Caciolla J., Mouawad N., Caligiuri I., Rizzolio F., Langer T., Minutolo F., Tuccinardi T. Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors. J. Enzym. Inhib. Med. Chem. 2018;33:956\u2013961. doi: 10.1080/14756366.2018.1469017.", "ArticleIdList": ["10.1080/14756366.2018.1469017", "PMC6009924", "29747534"]}, {"Citation": "Dal Piaz F., Ferro P., Vassallo A., Vasaturo M., Forte G., Chini M.G., Bifulco G., Tosco A., De Tommasi N. Identification and mechanism of action analysis of the new PARP-1 inhibitor 2\u2033-hydroxygenkwanol A. Biochim. Biophys. Acta Gen. Subj. 2015;1850:1806\u20131814. doi: 10.1016/j.bbagen.2015.05.014.", "ArticleIdList": ["10.1016/j.bbagen.2015.05.014", "25999161"]}, {"Citation": "Domotor O., Tuccinardi T., Karcz D., Walsh M., Creaven B.S., Enyedy E.A. Interaction of anticancer reduced Schiff base coumarin derivatives with human serum albumin investigated by fluorescence quenching and molecular modeling. Bioorg. Chem. 2014;52:16\u201323. doi: 10.1016/j.bioorg.2013.10.003.", "ArticleIdList": ["10.1016/j.bioorg.2013.10.003", "24291035"]}, {"Citation": "Milella L., Milazzo S., De Leo M., Vera Saltos M.B., Faraone I., Tuccinardi T., Lapillo M., De Tommasi N., Braca A. Alpha-Glucosidase and alpha-Amylase Inhibitors from Arcytophyllum thymifolium. J. Nat. Prod. 2016;79:2104\u20132112. doi: 10.1021/acs.jnatprod.6b00484.", "ArticleIdList": ["10.1021/acs.jnatprod.6b00484", "27509358"]}, {"Citation": "Granchi C., Caligiuri I., Bertelli E., Poli G., Rizzolio F., Macchia M., Martinelli A., Minutolo F., Tuccinardi T. Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors. J. Enzym. Inhib. Med. Chem. 2017;32:1240\u20131252. doi: 10.1080/14756366.2017.1375484.", "ArticleIdList": ["10.1080/14756366.2017.1375484", "PMC6009861", "28936880"]}, {"Citation": "Vine K.L., Belfiore L., Jones L., Locke J.M., Wade S., Minaei E., Ranson M. N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines. Heliyon. 2016;2:e00060. doi: 10.1016/j.heliyon.2015.e00060.", "ArticleIdList": ["10.1016/j.heliyon.2015.e00060", "PMC4945850", "27441242"]}, {"Citation": "Sevin M., Girodon F., Garrido C., de Thonel A. HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms. Mediat. Inflamm. 2015;2015:970242. doi: 10.1155/2015/970242.", "ArticleIdList": ["10.1155/2015/970242", "PMC4624912", "26549943"]}, {"Citation": "Bentires-Alj M., Barbu V., Fillet M., Chariot A., Relic B., Jacobs N., Gielen J., Merville M.P., Bours V. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene. 2003;22:90\u201397. doi: 10.1038/sj.onc.1206056.", "ArticleIdList": ["10.1038/sj.onc.1206056", "12527911"]}, {"Citation": "Kim H.B., Lee S.H., Um J.H., Oh W.K., Kim D.W., Kang C.D., Kim S.H. Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1. Oncotarget. 2015;6:36202\u201336218. doi: 10.18632/oncotarget.5343.", "ArticleIdList": ["10.18632/oncotarget.5343", "PMC4742171", "26416354"]}, {"Citation": "Yin L., Yang Y., Zhu W., Xian Y., Han Z., Huang H., Peng L., Zhang K., Zhao Y. Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3beta/beta-Catenin Signaling. Front. Oncol. 2021;11:620907. doi: 10.3389/fonc.2021.620907.", "ArticleIdList": ["10.3389/fonc.2021.620907", "PMC7960917", "33738259"]}, {"Citation": "Dinic J., Podolski-Renic A., Jovanovic M., Musso L., Tsakovska I., Pajeva I., Dallavalle S., Pesic M. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. Int. J. Mol. Sci. 2019;20:4575. doi: 10.3390/ijms20184575.", "ArticleIdList": ["10.3390/ijms20184575", "PMC6770006", "31527404"]}, {"Citation": "Bader A., Bkhaitan M.M., Abdalla A.N., Abdallah Q.M.A., Ali H.I., Sabbah D.A., Albadawi G., Abushaikha G.M. Design and Synthesis of 4-O-Podophyllotoxin Sulfamate Derivatives as Potential Cytotoxic Agents. Evid. Based Complement. Altern. Med. 2021;2021:6672807. doi: 10.1155/2021/6672807.", "ArticleIdList": ["10.1155/2021/6672807", "PMC7857870", "33574882"]}, {"Citation": "Al-Salem H.S., Arifuzzaman M., Alkahtani H.M., Abdaalla A.N., Issa I.S., Alqathama A., Albalawi F.S., Rahman A. A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor. Molecules. 2020;25:4400. doi: 10.3390/molecules25194400.", "ArticleIdList": ["10.3390/molecules25194400", "PMC7582667", "32992673"]}, {"Citation": "Al Bratty M., Makeen H.A., Alhazmi H.A., Syame S.M., Abdalla A.N., Homeida H.E., Sultana S., Ahsan W., Khalid A. Phytochemical, Cytotoxic, and Antimicrobial Evaluation of the Fruits of Miswak Plant, Salvadora persica L. J. Chem. 2020;2020:452195. doi: 10.1155/2020/4521951.", "ArticleIdList": ["10.1155/2020/4521951"]}, {"Citation": "Abdalla A.N., Abdallah M.E., Aslam A., Bader A., Vassallo A., Tommasi N., Malki W.H., Gouda A.M., Mukhtar M.H., El-Readi M.Z., et al. Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors. Molecules. 2020;25:2220. doi: 10.3390/molecules25092220.", "ArticleIdList": ["10.3390/molecules25092220", "PMC7248782", "32397330"]}, {"Citation": "Abdalla A.N., Shaheen U., Abdallah Q.M.A., Flamini G., Bkhaitan M.M., Abdelhady M.I.S., Ascrizzi R., Bader A. Proapoptotic Activity of Achillea membranacea Essential Oil and Its Major Constituent 1,8-Cineole against A2780 Ovarian Cancer Cells. Molecules. 2020;25:1582. doi: 10.3390/molecules25071582.", "ArticleIdList": ["10.3390/molecules25071582", "PMC7180961", "32235558"]}, {"Citation": "Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 2000;28:235\u2013242. doi: 10.1093/nar/28.1.235.", "ArticleIdList": ["10.1093/nar/28.1.235", "PMC102472", "10592235"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Granchi C., Lapillo M., Glasmacher S., Bononi G., Licari C., Poli G., El Boustani M., Caligiuri I., Rizzolio F., Gertsch J., et al. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor. J. Med. Chem. 2019;62:1932\u20131958. doi: 10.1021/acs.jmedchem.8b01483.", "ArticleIdList": ["10.1021/acs.jmedchem.8b01483", "30715876"]}, {"Citation": "Roe D.R., Cheatham T.E., 3rd PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J. Chem. Theory Comput. 2013;9:3084\u20133095. doi: 10.1021/ct400341p.", "ArticleIdList": ["10.1021/ct400341p", "26583988"]}, {"Citation": "Poli G., Gelain A., Porta F., Asai A., Martinelli A., Tuccinardi T. Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach. J. Enzym. Inhib. Med. Chem. 2016;31:1011\u20131017. doi: 10.3109/14756366.2015.1079184.", "ArticleIdList": ["10.3109/14756366.2015.1079184", "26308397"]}, {"Citation": "Eid S.Y., Althubiti M.A., Abdallah M.E., Wink M., El-Readi M.Z. The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. Phytomedicine. 2020;77:153280. doi: 10.1016/j.phymed.2020.153280.", "ArticleIdList": ["10.1016/j.phymed.2020.153280", "32712543"]}, {"Citation": "Eid S.Y., El-Readi M.Z., Eldin E.E., Fatani S.H., Wink M. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells. Phytomedicine. 2013;21:47\u201361. doi: 10.1016/j.phymed.2013.07.019.", "ArticleIdList": ["10.1016/j.phymed.2013.07.019", "23999162"]}, {"Citation": "Abdalla A.N., Qattan A., Malki W.H., Shahid I., Hossain M.A., Ahmed M. Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer. Molecules. 2020;25:4606. doi: 10.3390/molecules25204606.", "ArticleIdList": ["10.3390/molecules25204606", "PMC7594023", "33050377"]}, {"Citation": "Almasmoum H., Refaat B., Ghaith M.M., Almaimani R.A., Idris S., Ahmad J., Abdelghany A.H., BaSalamah M.A., El-Boshy M. Protective effect of Vitamin D3 against lead induced hepatotoxicity, oxidative stress, immunosuppressive and calcium homeostasis disorders in rat. Environ. Toxicol. Pharm. 2019;72:103246. doi: 10.1016/j.etap.2019.103246.", "ArticleIdList": ["10.1016/j.etap.2019.103246", "31465891"]}, {"Citation": "Abdallah M.E., El-Readi M.Z., Althubiti M.A., Almaimani R.A., Ismail A.M., Idris S., Refaat B., Almalki W.H., Babakr A.T., Mukhtar M.H., et al. Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules. 2020;25:3355. doi: 10.3390/molecules25153355.", "ArticleIdList": ["10.3390/molecules25153355", "PMC7436112", "32722075"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "5"}, {"Year": "2021", "Month": "12", "Day": "15"}, {"Year": "2021", "Month": "12", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "1", "Minute": "14"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["35011321", "PMC8746493", "10.3390/molecules27010090", "molecules27010090"]}}], "PubmedBookArticle": []}